Similar articles

• Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.

  Sharma AK, Kanawat DS, Mishra A, Dhakad PK, Sharma P, Srivastava V, Joshi S, Joshi M, Raikwar SK, Kurmi MK, Srinivasan BP. Sharma AK, et al. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):410-8. doi: 10.1177/1470320313475908. Epub 2013 Feb 8. J Renin Angiotensin Aldosterone Syst. 2014. PMID: 23396552
• Oral hypoglycemics and diabetic nephropathy.

  Hadler NM. Hadler NM. Clin J Am Soc Nephrol. 2008 Jan;3(1):159-62. doi: 10.2215/CJN.03730907. Clin J Am Soc Nephrol. 2008. PMID: 18178782 Review. No abstract available.
• Diabetic nephropathy: new approaches for improving glycemic control and reducing risk.

  Schernthaner G, Schernthaner GH. Schernthaner G, et al. J Nephrol. 2013 Nov-Dec;26(6):975-85. doi: 10.5301/jn.5000281. Epub 2013 Jun 14. J Nephrol. 2013. PMID: 23807645 Review.
• [Diagnosis, implication, prevention and treatment of microalbuminuria].

  Bothe D. Bothe D. Dtsch Med Wochenschr. 2012 Nov;137(46):2390; author reply 2390-1. doi: 10.1055/s-0032-1327215. Epub 2012 Nov 6. Dtsch Med Wochenschr. 2012. PMID: 23132160 German. No abstract available.
• Diabetes: Glycemic and blood-pressure control--lower is not better.

  Ruilope LM. Ruilope LM. Nat Rev Nephrol. 2012 Feb 14;8(4):199-200. doi: 10.1038/nrneph.2012.34. Nat Rev Nephrol. 2012. PMID: 22330972 No abstract available.